Codexis (CDXS) Free Cash Flow (2010 - 2026)
Codexis (CDXS) posted quarterly Free Cash Flow of -$13.8 million for Q1 2026, up 8.63% year-over-year from -$12.7 million in Q1 2025, and down 186.87% quarter-over-quarter from $15.8 million in Q4 2025.
Codexis (CDXS) Free Cash Flow (2010 - 2026) Analysis & Trends
Codexis' Free Cash Flow history runs 17 years deep, the most recent figure standing at -$13.8 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 8.63% year-over-year to -$13.8 million; the TTM figure through Mar 2026 stood at -$22.5 million (up 62.33% YoY), while the FY2025 annual figure was -$23.8 million, up 55.6% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$13.8 million, down from $15.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $18.4 million in Q3 2022, with the low at -$20.5 million in Q4 2024.
- The 5-year median for Free Cash Flow is -$12.3 million (2023), against an average of -$8.1 million.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow surged 356.43% in 2022, then slumped 328.63% in 2023.
- Codexis' Free Cash Flow stood at $12.4 million in 2022, then plunged by 223.75% to -$15.3 million in 2023, then plunged by 34.18% to -$20.5 million in 2024, then jumped by 177.14% to $15.8 million in 2025, then sank by 186.87% to -$13.8 million in 2026.
- Business Quant data shows CDXS's Free Cash Flow at -$13.8 million in Q1 2026, $15.8 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | -10.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.11 Mn |
| Jun 30, 2026 | -10.11 Mn |
| Mar 31, 2026 | -13.75 Mn |
| Mar 31, 2026 | -13.75 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Dec 31, 2025 | 15.83 Mn |
| Sep 30, 2025 | -7.87 Mn |
| Sep 30, 2025 | -7.87 Mn |
| Jun 30, 2025 | -16.76 Mn |
| Jun 30, 2025 | -16.76 Mn |
| Mar 31, 2025 | -15.05 Mn |
| Mar 31, 2025 | -15.05 Mn |
| Dec 31, 2024 | -20.52 Mn |
| Dec 31, 2024 | -20.52 Mn |
| Sep 30, 2024 | -11.71 Mn |
| Sep 30, 2024 | -11.71 Mn |
| Jun 30, 2024 | -12.56 Mn |
| Jun 30, 2024 | -12.56 Mn |
| Mar 31, 2024 | -8.92 Mn |
| Mar 31, 2024 | -8.92 Mn |